Missouri's highest court on Tuesday refused to consider Johnson & Johnson's appeal of a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in its baby powder and other talc products. Bryan Wood reports.
AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on Friday. Fred Katayama reports.
After claiming 92% efficiency on November 11, now Russia's developers of the Sputnik V Covid-19 vaccine candidate say that their vaccine is 95% effective. The latest report was released after a second..